Your session is about to expire
← Back to Search
Dietary Supplement
Efficacy and Safety Safety of Nutritears® in Adults With Dry Eye Syndrome
N/A
Waitlist Available
Research Sponsored by Applied Science & Performance Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, day 14, day 28, day 56
Summary
This trial tests Nutritears®, a dietary supplement, in adults with dry eye syndrome. The supplement aims to improve tear production and stability, helping to relieve dry eye symptoms.
Eligible Conditions
- Dry Eye Syndrome
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, day 14, day 28, day 56
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, day 14, day 28, day 56
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Ocular Surface Disease Index (OSDI) score
Schirmer's Test (without anesthesia)
Secondary study objectives
Corneal and Conjunctival Staining
MMP-9
Rescue Medication Use
+3 moreOther study objectives
Changes in Alanine Transaminase levels
Changes in Albumin levels
Changes in Albumin to Globulin ratio
+35 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Dietary supplementExperimental Treatment1 Intervention
Consume one capsule every morning after the breakfast at the same time every day for 56 days
Group II: PlaceboPlacebo Group1 Intervention
Consume one capsule every morning after the breakfast at the same time every day for 56 days
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nutritears®
2022
N/A
~140
Find a Location
Who is running the clinical trial?
True Eye Experts - LutzUNKNOWN
True Eye Experts - New TampaUNKNOWN
1 Previous Clinical Trials
15 Total Patients Enrolled
True Eye Experts - South TampaUNKNOWN
Applied Science & Performance InstituteLead Sponsor
15 Previous Clinical Trials
963 Total Patients Enrolled